Crossmark

Perinatal origins of chronic lung disease: mechanisms–prevention–therapy—sphingolipid metabolism and the genetic and perinatal origins of childhood asthma

Crossref DOI link: https://doi.org/10.1186/s40348-021-00130-y

Published Online: 2021-12-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wasserman, Emily

Worgall, Stefan
Funding

Funding for this research was provided by:

National Institute of Allergy and Infectious Diseases (R21 AI140724)

National Center for Advancing Translational Sciences (KL2 TR0002385)
License Information

Text and Data Mining valid from 2021-12-20

Version of Record valid from 2021-12-20
More Information

Article History

Received: 2 September 2021

Accepted: 16 November 2021

First Online: 20 December 2021

Declarations

:

: Not applicable

: Not applicable

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below